Old Mission Capital’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Old Mission Capital’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,031	Closed	-$528K	–	1157
2025 Q4	$528K	Buy	+16,031	New	+$499K	0.01%	657
2025 Q2	–	Sell	-15,740	Closed	-$433K	–	1151
2025 Q1	$433K	Buy	+15,740	New	+$436K	0.01%	672
2024 Q3	–	Sell	-19,459	Closed	-$530K	–	1554
2024 Q2	$530K	Buy	+19,459	New	+$521K	0.01%	704
2024 Q1	–	Sell	-7,907	Closed	-$210K	–	1421
2023 Q4	$210K	Buy	+7,907	New	+$199K	﹤0.01%	1059
2023 Q3	–	Sell	-21,683	Closed	-$568K	–	1390
2023 Q2	$568K	Buy	+21,683	New	+$573K	0.01%	608

Other funds holding FTXH

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Old Mission Capital's FTXH Position: Q1 2026 in Review

Old Mission Capital sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2026, closing a stake of 16,031 shares — an estimated $528K sold.

Old Mission Capital first reported a position in FTXH in Q2 2023 and held it in 5 quarters. The position peaked at $568K in Q2 2023. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

Old Mission Capital reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q1 2026 after selling out during the quarter.
Old Mission Capital sold 16,031 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2026, an estimated $528K.
Old Mission Capital first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2023 and held it in 5 quarters.
Old Mission Capital's First Trust Nasdaq Pharmaceuticals ETF position peaked at $568K in Q2 2023.
32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Old Mission Capital's 13F filing for Q1 2026, filed 15 May 2026.